Three New Agreements to Expand Access to HIV Treatment

Published October 10th, 2017

In 2015, CHAI, with the support of Unitaid, UNAIDS and the United Kingdom’s Department for International Development (DFID), negotiated three new agreements that could increase access to more sustainable HIV drug regimens at reduced prices, including a tenofovir-based first-line regimen available for less than US$100 per patient per year.